Navigation Links
Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
Date:10/27/2008

Encouraging Clinical Data Presented at American College of Rheumatology (ACR) meeting Show Reduced Need for Concomitant Corticosteroid Therapy

SAN FRANCISCO, Oct. 27 /PRNewswire-FirstCall/ -- UCB (Euronext Brussels: UCB) announced data from two randomized controlled trials showing that treatment with epratuzumab a humanized anti-CD22 antibody, resulted in clinically meaningful reduced disease activity, improved health-related quality of life (HRQoL) measurements and reduced reliance on corticosteroids compared to placebo treatment in patients with active moderate and severe systemic lupus erythematosus (SLE). These findings were presented at the American College of Rheumatology (ACR) annual meeting here today.

"Given the debilitating effect lupus has on a patient's quality of life, these results are encouraging," commented lead study investigator Daniel J. Wallace, M.D., Clinical Professor of Medicine, David Geffen School of Medicine, UCLA. "In these trial results, treatment with epratuzumab demonstrated clinically meaningful improvement in patients' flares and significant decrease in steroid use, which is critical given their long-term adverse effects."

"While medical advances have improved the lives and survival of people with lupus, effective therapeutic options remain limited," said Sandra C. Raymond, President and Chief Executive Officer of the Lupus Foundation of America. "It has been nearly five decades since a new treatment was approved for this devastating and life altering disease and current treatments are limited with adverse effects though recent research efforts to find new treatments are encouraging for the millions of people around the world living with lupus."

In the combined studies, beginning at week 4 and continuing through week 48, Total BILAG* scores, a clinical measure of lupus disease activity, in both epratuzumab treatment arms (360 or 720mg/m2) remained lower than placebo. Among study participants who comp
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 21. November 2014 Michael DeMarco ... Morgen des 14. Februar 2014 zugetragen hat. Seine Tochter ... vergessen. Video - http://youtu.be/5cVoMCe0uiE ... war, mein morgendliches Training zu machen", erzählt Michael ... der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war ...
(Date:11/21/2014)... BEVERLY HILLS, Calif. , Nov. 20, 2014 ... Ken Eaton , the election of Anthony J. ... as President. Effective November 19, 2014, ... and member of the Board of Directors of Oxis International, ... J. Cataldo has been named Chief Executive Officer of ...
(Date:11/21/2014)... THE WOODLANDS, Texas , Nov. 21, 2014 /PRNewswire/ ... announced that it has priced its offering of $80,000,000 ... 2021 (the "Convertible Notes") in a private offering within ... Notes were offered to qualified institutional buyers pursuant to ... amended (the "Securities Act"). Lexicon has also granted the ...
Breaking Medicine Technology:Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3
... ARBOR, Mich., March 19, 2012 SARC, Sarcoma Alliance ... group, announced that on Tuesday, March 20, 2012, the ... Committee (ODAC) will review two New Drug Applications submitted ... for their drugs for the treatment of sarcoma.  Sarcoma ...
... March 19, 2012  BioDelivery Sciences International, Inc. (NASDAQ: ... Annual Report on Form 10-K for the year ended ... Commission and, in connection therewith, is providing a review ... operations and upcoming milestones for 2012. (Logo:  ...
Cached Medicine Technology:FDA's Oncologic Drugs Advisory Committee to Review Two New Drug Applications for Sarcoma on Tuesday, March 20, 2012 2BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 2BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 3BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 4BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 5BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 6BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 7BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 8
(Date:11/22/2014)... Petersburg, FL (PRWEB) November 22, 2014 ... Kitchen Innovations are pleased to announce that Ashley ... the Thanksgiving #PayItForward contest. , Ms. Lombardo entered ... from Kitchen Innovations. She wrote of how her friend ... young daughters as a single mom. Despite medical bills ...
(Date:11/22/2014)... November 22, 2014 Sandbridge Capital, ... investments in the consumer brand sector, acquired a ... will be used to help fund BackJoy’s global ... rollout, particularly its proprietary apparel and footwear lines. ... BackJoy’s Board of Directors. , BackJoy is a ...
(Date:11/22/2014)... 22, 2014 Developers and plugin specialist of ... entitled FCPX 3D Model bringing the impossible to FCPX ... users to add obj files to FCPX enabling 3d Model ... the line between professional and armature, FCPX 3D Model is ... Studios allows Final Cut Pro X users to upload and ...
(Date:11/22/2014)... 22, 2014 Wright & Schulte LLC ... lawsuits have been scheduled between October 2016 and ... of Illinois. U.S. District Judge Matthew F. Kennelly, who ... Management Order (CMO) on November 6, 2014 that outlined ... to submit documents and other activities in preparation for ...
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- A clinical ... anemia has been halted a year early because the ... to manage the disease and reduce the risk of ... conducted at 25 medical centers in the United States ... National Heart, Lung, and Blood Institute (NHLBI). Researchers ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... planning association all worked up. With the fertility rate ... demographers are pressing the need of 2.1 children per ... ,A survey conducted by the Family Planning Association revealed ... indulge in sex for over a month. There was ...
... must before marriage, say an overwhelming 91 percent in an ... cases.// ,The survey, conducted by manoramaonline/yuva, saw 22,578 ... certificate was a must before marriage. Just 2,032 said that ... have just been published. ,According to the Kerala ...
... is only for the white collar tech-savvy urbanites, think again. ... acquired smart// cards to avail themselves of discounts on daily ... 500 disorganised sex workers in Mysore and Mandya districts of ... prompt them to get regular health check ups to keep ...
... and less inclined to follow a career in general practice, ... of Australia.// ,Dr Catherine Joyce, Senior Lecturer in ... and co-author of the study, says places in the general ... of the past six years. ,The study compared ...
... the growing problem of obesity in Australians by looking at ... in the latest edition of The Medical Journal of Australia, ... (GP) about weight management. ,Levels of overweight and ... past two decades. ,Dr Daisy Tan, Advanced ...
... "Lets Stop Aids Org" is currently touring South Africa to ... living with HIV/Aids.// ,Betty Chiu, a member of ... week. She is encouraging other youngsters to follow her example ... 'Lets Stop Aids Org' was established three years ago at ...
Cached Medicine News:Health News:Majority of Keralites Vote in Favor of HIV Certificate Before Marriage 2Health News:Sex Workers Adopt IT Solutions to Fight AIDS 2
... system continues the "Consensus Concept" approach ... with the diversified experience of a ... an affordable knee system that incorporates ... designed to provide both joint and ...
... The Optetrak system includes a cruciate ... Patellar flange mates with both resurfacing ... assure precise, repeatable kinematics and fit ... to reduce wear. Constant cutting guide ...
... result of more than a decade of ... on a comprehensive study of knee kinematics ... tibial insert retrieval analysis.,As a result of ... and motion patterns in total knees, the ...
... The Foundation® PS knee offers a femoral option ... cam action that engages at 60 degrees of ... motion and allow for 130 degrees of flexion. ... design with prominent lateral flare. The constrained tibial ...
Medicine Products: